Pilot study of organ preservation multimodality therapy for locally advanced resectable oropharyngeal carcinoma

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 23, Issue 5, 2000, Pages 509-515

  Machtay, Mitchell ^a   Rosenthal, David I ^a   Algazy, Kenneth M ^a   Aviles, Victor M ^a   Chalian, Ara A ^a   Hershock, Diane ^a   Neubauer, Robin ^a   Greenberg, Michael J ^a   Mirza, Natasha ^a   Weinstein, Gregory S ^a   Weber, Randal S ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Multimodality therapy; Organ preservation; Oropharyngeal carcinoma; Pilot study

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CONTROL; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG EFFICACY; FEBRILE NEUTROPENIA; FEMALE; HUMAN; MALE; MAXIMUM TOLERATED DOSE; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NECK DISSECTION; OROPHARYNX CARCINOMA; PNEUMONIA; QUALITY OF LIFE; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; HUMANS; LARYNGECTOMY; NECK DISSECTION; OROPHARYNGEAL NEOPLASMS; PACLITAXEL; PILOT PROJECTS; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS;

EID: 0034441943     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200010000-00016     Document Type: Article

References (30)

1. Combined radiation therapy and surgery in the management of advanced head and neck cancer: Final report of study 73-03 of the Radiation Therapy Oncology Group
2. An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts
3. Long-term treatment results of postoperative radiation therapy for advanced stage oropharyngeal carcinoma
4. Locally advanced resectable oropharyngeal carcinoma: High local-regional control but a high rate of distant metastases with surgery and postoperative radiotherapy
5. Adjuvant chemotherapy for advanced head and neck squamous cell carcinoma: Final report of Head Neck Contracts Program
6. Induction chemotherapy in advanced head and neck tumors: Results of two randomized trials
7. Why has induction chemotherapy for advanced head and neck cancer become a United States community standard of practice?
8. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer
9. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study
10. An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer
11. Combination of cisplatin, oncovin, and bleomycin prior to surgery and/or radiotherapy in advanced untreated epidermoid cancer of the head and neck
12. Superior clinical response and survival rates with initial bolus of cisplatin and 120 hours infusion of 5-fluorouracil before definitive therapy for locally advanced head and neck cancer
13. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer
14. Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer Phase III trial
15. Chemoradiotherapy for advanced inoperable head and neck cancer: A phase II study
16. Multimodality therapy of patients with locally advanced squamous cell cancer of the head and neck: Preliminary results of two pilot trials using paclitaxel and cisplatin
17. Radiotherapy and concomitant weekly 1-hour infusion of paclitaxel in the treatment of head and neck cancer - Results from a phase I trial
18. Prophylactic gastrostomy tubes in patients undergoing intensive irradiation for cancer of the head and neck
19. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099
20. A phase I study of weekly paclitaxel and cisplatin concurrent with postoperative radiation therapy for treatment of high-risk patients with squamous cell cancer of the head and neck
21. A review of neoadjuvant chemotherapy for head and neck cancer: Partially shrunken tumors may be both leaner and meaner
22. Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin
23. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results
24. Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with G-CSF support for patients with poor prognosis cancer of the head and neck
25. Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: An Eastern Cooperative Oncology Group trial
26. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer
27. Biomarkers in upper aerodigestive tract tumorigenesis: A review
28. Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: A prospective examination
29. A performance status scale for head and neck cancer patients